We evaluated the two argon-enhanced coagulation (AEC) systems currently on the market from two different manufacturers, basing our ratings primarily on performance and safety and considering the clinical perspectives gained from discussions with surgeons who use these units. We rated both units Acceptable. Because one unit has characteristics that provide a potential safety advantage (i.e., it produces lower gas pressure at the tissue and limits certain gas flow/power combinations), we ranked it slightly higher than the other unit. However, sufficient laboratory and clinical studies must still be carried out to assess the risk of gas embolism with these and future systems.
我们评估了市场上目前由两家不同制造商生产的两种氩气增强凝血（AEC）系统，我们的评级主要基于性能和安全性，并考虑了与使用这些设备的外科医生讨论后获得的临床观点。我们对这两种设备的评级均为“可接受”。由于其中一种设备具有潜在的安全优势（即它在组织处产生较低的气压，并限制了某些气体流量/功率组合），我们将其排名略高于另一种设备。然而，仍必须进行充分的实验室和临床研究，以评估这些系统以及未来系统发生气体栓塞的风险。
